REGISTER FOR TOUCH BRIEFINGS |
|
|
|
Register for touch briefings
|
|
|
|
|
|
|
|
Touch Briefings welcomes editorial submissions for inclusion within our print reports and website from industry practitioners.
|
|
|
|
|
|
EUROPEAN HAEMATOLOGY - VOL 2 ISS 1 |
|
Contents:
Contents
Advisory Panel
Foreword
|
Foreword
Luigi D Notarangelo
Chair, Paediatric Immunology Research, and Professor of Paediatrics and Pathology, Harvard Medical School
|
Editors Choice
|
|
Snake Venom and Haemostasis – An Overview
Ponlapat Rojnuckarin
Head, Division of Haematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
|
Coagulation Disorders
|
|
Awareness of Mild Bleeding Disorders
Pieter W Kamphuisen
Department of Vascular Medicine, Academic Medical Centre, Amsterdam
|
|
|
Inhibitors in Haemophilia A – Ongoing Research and Clinical Practice
Wolfhart Kreuz,1 Carmen Escuriola-Ettingshausen1 and Günter Auerswald2
1. Centre of Paediatrics III, Department of Haematology, Oncology and Haemostaseology, Johann-Wolfgang-Goethe University Hospital, Frankfurt; 2. Prof.–Hess Children’s Hospital, Klinikum Bremen-Mitte, Bremen
|
|
|
Haemophilia Treatment – Current and Future Challenges
J Blatny? ,1 J Ingerslev,2 A Huth-Kühne,3 T Lambert4 and J Windyga5
1. Children’s University Hospital, Brno; 2. Aarhus University; 3. Kurpfalzkrankenhaus Hemophilia Centre, Heidelberg; 4. Assistance Publique, Hôpitaux de Paris; 5. Institute of Transfusion Medicine, Warsaw
|
|
|
Immunological Aspects of Inhibitor Development in Haemophilia
David Keeling1 and Cindy Lee2
1. Consultant Haematologist, Oxford Radcliffe Hospitals, and Honorary Senior Clinical Lecturer in Haematology, University of Oxford; 2. Staff Medical Writer, Touch Briefings
|
|
|
Long-term Prophylaxis in von Willebrand Disease – How Should It Be Given and for Whom?
Erik Berntorp, Sharyne M Donfield and Thomas C Abshire
The von Willebrand Disease Prophylaxis (VIP) Study Group
|
|
|
Current Management of von Willebrand Disease
Augusto B Federici
Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Department of Medicine and Medical Specialities, IRCCS Maggiore Policlinico Hospital, Mangiagalli
|
|
|
Congenital Disorders of Platelet Function
Gian Marco Podda, Mariateresa Pugliano and Marco Cattaneo
San Paolo Hospital, Department of Medicine, Surgery and Dentistry, University of Milan
|
Thrombosis
|
|
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis
Mirjam E Meltzer,1,2 Frits R Rosendaal2 and Ton Lisman1,3
1. Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht; 2. Department of Clinical Epidemiology, Leiden University Medical Centre; 3. Surgical Research Laboratory, Department of Surgery, University Medical Centre Groningen, University of Groningen
|
Haemoglobinopathies
|
|
Breaking New Ground in Intravenous Iron Therapy
George R Bailie
Professor of Pharmacy, Albany College of Pharmacy and Health Sciences, New York
|
|
|
Innovative Drug Design Using RNA Aptamers for Various Anaemias
Jun-ichi Nishimura,1,2 Marilyn J Telen3 and Bruce A Sullenger4
1. Department of Haematology and Oncology, Osaka University Graduate School of Medicine; 2. Division of Cellular Therapy, Duke University Medical Center; 3. Division of Hematology, Duke University Medical Center; 4. Division of Experimental Surgery, Duke University Medical Center
|
Transplantation
|
|
Indirect Effects of Cytomegalovirus
Cecilia Söderberg-Nauclér
Department of Medicine, Centre for Molecular Medicine, Karolinska University Hospital Solna, and Karolinska Institute, Stockholm
|
Infection in Haematology
|
|
Prevention of Mother-to-child Transmission of HIV
Jennifer S Read
Medical Officer, Paediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
|
Haematological Malignancies
|
|
Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myeloid Leukaemia
K Hellstrand, AI Romero and M Brune
Department of Infectious Diseases and Haematology, Sahlgren’s Academy, Gothenburg University
|
|
|
The Harmful Effects of Iron Overload in Patients with Myelodysplastic Syndrome
Andrea Toma1 and François Dreyfus2
1. Clinical Haematology Department, Pitié Salpetrière Hospital, Paris; 2. Professor of Medicine, University of Paris Descartes–Paris V, and Head, Haematology Unit, Hospital Cochin, Paris
|
|
|
Proteomics in Myeloproliferative Disorders
Pascal Mossuz
Haematology Laboratory, University Hospital Grenoble
|
Surgery
|
|
Peri-operative Goal-directed Haemodynamic Therapy – Why Are We Where We Are Now, and What Is Needed to Move Forward?
Peter Isherwood1 and Owen Boyd2
1. Specialist Registrar in Anaesthesia, Royal Sussex County Hospital, Brighton; 2. Consultant and Director, Intensive Care, Brighton and Sussex University Hospitals NHS Trust
|
Transfusion
|
|
Neutralising Pathogens in Blood in Developing Countries – Thinking Outside the Screening Box
Gadi Borkow1 and Abdoulaye Doucoure2
1. Cupron Incorporated, Israel; 2. Pall Corporation, Port Washington
|
Paediatric Haematology
|
|
Arterial-pressure-based Continuous Cardiac Output Monitoring in Paediatric Patients
Joris Lemson
Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre
|
|
|
|
|
|
